Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
UAE Releases 2025 Annual Nuclear Regulatory Report, Highlighting Nuclear Safety and Peaceful Use Achievements
The UAE Federal Authority for Nuclear Regulation (FANR) has released its "2025 Annual Report," showcasing regulatory progress over the past year in nuclear safety, radiation protection, and nuclear non-proliferation. The report indicates that the UAE continues to advance its nuclear governance framework in line with the "We the UAE 2031" vision, enhancing regulatory efficiency while emphasizing that nuclear technology and nuclear materials must serve peaceful purposes. The report specifically highlights FANR's launch of a unified import and export system. This digital platform is designed to streamline the regulatory processes for the import and export of nuclear and radioactive materials, while strengthening regulatory transparency and traceability. The development of this system demonstrates that the UAE is focused not only on the safety of nuclear facilities themselves...
2026-08-13
French nuclear fleet output drops to 59% of full capacity
2026-08-13
Egypt Plans to Expand Dabaa Nuclear Power Plant, Talks on New Reactors Signal Energy Transition
2026-08-13
Türkiye Maps Out Small Modular Reactors, Targeting 5,000 MW Installed Capacity by 2050
2026-08-13
Major Fusion Energy Appointment in the UK: MIT Professor Dennis Whyte Named CEO of UKAEA
2026-08-13
Russia's National Anti-Terrorism Committee Demands Enhanced Security for Energy and Nuclear Facilities
2026-08-13
Poland's First Nuclear Power Plant Enters New Phase with Deepening Polish Enterprise Participation
2026-08-13
Rising River Water Temperatures in Europe Constrain Nuclear Power Operations, Poland's First Nuclear Power Plant Turns to Baltic Sea for Cooling Water
2026-08-13
Czech Republic Proposes Amendments to Low-Carbon Act, Key Dukovany Nuclear Contracts May Exit Public Registry
2026-08-13
The integration of nuclear technology with agricultural production is demonstrating increasingly tangible value in Indian farmlands. Through radiation-induced mutation and hybrid breeding techniques, the Bhabha Atomic Research Centre in India has successively developed 72 improved crop varieties, covering peanuts, rice, mung beans, mustard, and other crops. India's Minister of State Jitendra Singh disclosed this progress in a written reply to Parliament, showing that the peaceful application of nuclear science has extended from laboratories to the frontlines of agricultural production. In terms of variety composition, peanut new varieties are the most numerous, reaching 17; rice has 10, mung beans and mustard 9 each, black gram 8, pigeon pea 5, sorghum 3, and cowpea, wheat, and soybean 2 each. Additionally...
2026-08-13
US biotechnology company Valion Bio announced on August 12 that the safety study of its investigational therapeutic candidate Entolimod for radiation-induced gastrointestinal injury is scheduled to commence this week. The study is being advanced by the Armed Forces Radiobiology Research Institute (AFRRI) under a contract with the National Institute of Allergy and Infectious Diseases (NIAID), as part of a government-funded research program. According to the company's disclosure, Entolimod has been delivered to AFRRI, the study has received approval from the Institutional Animal Care and Use Committee (IACUC), and the experimental animals are currently in the pre-dosing acclimation phase. The safety study will confirm the tolerability of Entolimod in the animal strain used by AFRRI...
2026-08-13
ASP Isotopes Inc. recently presented its expansion plans for isotope production, radiopharmaceuticals, and helium operations at Canaccord Genuity's 46th Annual Growth Conference. The company aims to begin commercial delivery of stable isotopes including silicon-28, carbon-14, and ytterbium-176 in the second half of 2026. Victor Petkov, the company's Chief Commercial Officer, stated that ASP Isotopes is leveraging its proprietary enrichment technology to serve electronics, nuclear medicine, and nuclear fuel-related markets. Currently, the company operates three production facilities in Pretoria, South Africa, primarily producing silicon-28 for semiconductor applications, as well as carbon-14 and ytterbium-176 for nuclear medicine-related uses. Regarding isotope supply...
2026-08-13
Anhui Juhe Haizhi Technology Co., Ltd., jointly established by Jianghuai Laboratory, the Institute of Energy at Hefei Comprehensive National Science Center, Keda Silicon Valley, and Anhui Penggong Intelligent Equipment Technology Co., Ltd., has officially settled in Hefei. The company focuses on the industrialization of embodied intelligent equipment for extreme environments, with key deployments in high-risk operational scenarios such as nuclear radiation, deep sea, and specialty chemicals. Juhe Haizhi plans to release two embodied intelligent robots for extreme environments by the end of August 2026. Among them, the commercial fusion radiation-resistant maintenance robot is one of the key products to be released, providing unmanned intelligent maintenance solutions for nuclear radiation-related scenarios, with neutron target maintenance for Boron Neutron Capture Therapy (BNCT) devices being one of its core application scenarios...
2026-08-13
August 12 news, Xi'an Maistop Technology Co., Ltd. recently completed its Pre-A round of financing, with investors including the Central Enterprise Strategic Emerging Fund and Guoxin Venture Capital Fund, both under China Reform Holdings Corporation. The proceeds from this round will primarily be used for site construction, equipment procurement, technology R&D, and daily operations. Founded in 2019, Maistop is a technology enterprise engaged in the R&D and production of medical radionuclides as well as nuclear medicine technical services. The company focuses on the preparation of medical radionuclides via the electron accelerator photonuclear reaction method, with core products including Actinium-225, Lead-212, Copper-67, and Molybdenum-99. Among these, Actinium-225 is a scarce radionuclide of significant interest in alpha-emitting nuclide targeted therapy, with relatively strong global clinical demand...
2026-08-13
On August 10, the Mianyang Science and Technology City Strategic Development Research Center held an online innovation achievement release conference, unveiling a medical radioactive waste treatment technology developed by the School of National Defense Science and Technology / School of Nuclear Science and Technology at Southwest University of Science and Technology. The technology targets radioactive contaminants including liquid waste, off-gas, and solid waste generated during nuclear medicine diagnosis and treatment, offering a full-chain comprehensive treatment solution. The conference attracted 87,000 experts in the nuclear medicine field, departmental representatives, and enterprise users. With the rapid development of the domestic nuclear medicine industry, insufficient radioactive waste disposal capacity has gradually become a key issue facing the industry's safe expansion. Relevant data show that over 96% of nuclear medicine departments nationwide are constrained by decay tank capacity...
2026-08-13
The American Society for Radiation Oncology (ASTRO) Foundation will award a total of $2.4 million in research grants to 14 scientists dedicated to advancing patient care in radiation medicine. ASTRO stated that the 2026 awards are the first annual grants issued since the society renamed its foundation to LightSpeed—ASTRO Foundation earlier this year. The rebranded foundation will focus on accelerating relevant research and strengthening workforce development in the field of radiation oncology. This round of funding is co-sponsored by the American Cancer Society, the American Association of Physicists in Medicine, the Breast Cancer Research Foundation, the LUNGevity Foundation, and the Prostate Cancer Foundation. ASTRO CEO Vive...
2026-08-13
